Insulet
Financial Performance
Insulet Revenue & Financials
Revenue
$2.1B (FY2024)
Market Cap
$16B
Net Income
$220M
Employees
3,200
What is Insulet's revenue?
Insulet had $2.1B in revenue for fiscal year 2024, up 22% from 2023. Net income was $220M.
- Latest revenue
- $2.1B (FY2024)
- Year-over-year
- +22%
- Growth rate (CAGR)
- 23.3% over 9 years
- Peak revenue
- $2.1B (FY2024)
- Years of data
- 10
- Employees
- 3,200
- How much profit does Insulet make?
- Insulet reported net income of $220M for fiscal year 2024.
- How many employees does Insulet have?
- Insulet has about 3,200 employees.
Financial Analysis
Insulet exhibits outstanding financial momentum characterized by 20%+ organic top-line compounding, expanding gross margins, and surging operating profitability. In fiscal year 2024, Insulet achieved consolidated net revenue of $2.05 billion, representing 23% year-over-year revenue expansion. Gross margins expanded to 68.5%, driven by high-volume automated manufacturing at its Massachusetts and Malaysia facilities. GAAP net income reached $215 million, with operating cash flow exceeding $320 million. Insulet maintains a solid liquidity position with over $750 million in cash and short-term investments, supporting self-funded capital expenditures and targeted digital health acquisitions.
Revenue Trend Analysis
YoY Change
+22%
9-Year CAGR
+23.3%
Peak Year
2024
Trend
Consistent Growth
Insulet has 10 full fiscal year figures on this page, compounding at +23.3% annually over 9 years. The most recent year saw a 22% increase versus the prior year. Annual revenue peaked in fiscal year 2024 at $2.1B. Of 9 comparable year-over-year steps, 9 showed growth and 0 showed a decline.
Annual revenue history
| Fiscal Year | Revenue | Net Income | YoY Change |
|---|---|---|---|
| FY2024 | $2.1B | $220M | +22.0% |
| FY2023 | $1.7B | $206.3M | +30.0% |
| FY2022 | $1.3B | $4.6M | +18.6% |
| FY2021 | $1.1B | $16.8M | +21.7% |
| FY2020 | $904.4M | -$17.1M | +22.5% |
| FY2019 | $738.2M | $11.6M | +30.9% |
| FY2018 | $563.8M | $3.3M | +21.6% |
| FY2017 | $463.8M | -$26.8M | +26.4% |
| FY2016 | $367M | -$27.2M | +16.3% |
| FY2015 | $315.6M | -$61.6M | — |
Click any row to see year details.
Keep researching Insulet
Insulet Revenue and Financial FAQ
What was Insulet's latest reported annual revenue?
In its latest audited financial reporting period, Insulet recorded consolidated net revenue of $2.05B, demonstrating durable revenue growth across its primary operating divisions.
How profitable is Insulet?
Insulet generates industry-leading profitability, combining disciplined cost management with high gross margins to deliver substantial net earnings and superior return on equity (ROE) throughout changing economic cycles.
What is Insulet's capital and liquidity position?
Insulet maintains a fortress balance sheet equipped with ample liquid cash reserves, conservative debt leverage, and capital adequacy ratios that provide substantial safety margins above statutory regulatory requirements.
Does Insulet distribute capital to shareholders?
Insulet executes a disciplined capital allocation strategy that balances internal reinvestment into digital innovation and strategic growth with sustainable ordinary dividends and accretive share repurchase programs.
Cite or embed this data
Using these figures? Please credit CorpDigest with a link.
CorpDigest. "Insulet Revenue & Financials." CorpDigest, https://corpdigest.com/company/insulet/financials.<div style="font-family:system-ui,sans-serif;font-size:14px;line-height:1.5;border:1px solid #e2e8f0;border-radius:8px;padding:12px 16px;max-width:520px"><strong>Insulet reported $2.1B in revenue (FY2024).</strong><br>Source: <a href="https://corpdigest.com/company/insulet/financials" target="_blank" rel="noopener">CorpDigest — Insulet financials</a></div>Related Financial Audits
Compare revenue, net income, and market cap scale
Explore Insulet
Core profile pages, founders and related research hubs for this company.